New Orphan Drug Kynamro Approved For Inherited Cholesterol Disorder
Kynamro (mipomersen sodium) injection has been approved by the FDA to treat people who are genetically predisposed to have high
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓